Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis

A Booth, AB Reed, S Ponzo, A Yassaee, M Aral… - PloS one, 2021 - journals.plos.org
Aim COVID-19 clinical presentation is heterogeneous, ranging from asymptomatic to severe
cases. While there are a number of early publications relating to risk factors for COVID-19 …

Case fatality rates for patients with COVID-19 requiring invasive mechanical ventilation. A meta-analysis

ZJ Lim, A Subramaniam, M Ponnapa Reddy… - American journal of …, 2021 - atsjournals.org
Rationale: Initial reports of case fatality rates (CFRs) among adults with coronavirus disease
(COVID-19) receiving invasive mechanical ventilation (IMV) are highly variable. Objectives …

Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers: a randomized clinical trial

BS Abella, EL Jolkovsky, BT Biney… - JAMA internal …, 2021 - jamanetwork.com
Importance Health care workers (HCWs) caring for patients with coronavirus disease 2019
(COVID-19) are at risk of exposure to severe acute respiratory syndrome coronavirus 2 …

[HTML][HTML] Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortality

J Silva, C Lucas, M Sundaram, B Israelow, P Wong… - MedRxiv, 2021 - ncbi.nlm.nih.gov
While several clinical and immunological parameters correlate with disease severity and
mortality in SARS-CoV-2 infection, work remains in identifying unifying correlates of …

The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: a pooled analysis

L Luo, M Fu, Y Li, S Hu, J Luo, Z Chen, J Yu… - Clinical …, 2020 - Wiley Online Library
Backgroud The association between underlying comorbidities and cardiac injury and the
prognosis in coronavirus disease 2019 (COVID‐19) patients was assessed in this study …

[HTML][HTML] Chronic diseases as a predictor for severity and mortality of COVID-19: a systematic review with cumulative meta-analysis

JS Geng, XL Yu, HN Bao, Z Feng, XY Yuan… - Frontiers in …, 2021 - frontiersin.org
Introduction: Given the ongoing coronavirus disease 2019 (COVID-19) pandemic and the
consequent global healthcare crisis, there is an urgent need to better understand risk factors …

Circulating calprotectin as a biomarker of COVID-19 severity

M Mahler, PL Meroni, M Infantino… - Expert review of …, 2021 - Taylor & Francis
ABSTRACT Introduction Coronavirus disease 2019 (COVID-19) is an infectious disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …

Predicting COVID-19—comorbidity pathway crosstalk-based targets and drugs: towards personalized COVID-19 management

D Barh, AA Aljabali, MM Tambuwala, S Tiwari… - Biomedicines, 2021 - mdpi.com
It is well established that pre-existing comorbid conditions such as hypertension, diabetes,
obesity, cardiovascular diseases (CVDs), chronic kidney diseases (CKDs), cancers, and …

COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies

Cochrane Heart Group, P Pellicori… - Cochrane Database …, 1996 - cochranelibrary.com
Background A small minority of people with coronavirus disease 2019 (COVID‐19) develop
a severe illness, characterised by inflammation, microvascular damage and coagulopathy …

Prevalence and impact of comorbidities on disease prognosis among patients with COVID-19 in Bangladesh: a nationwide study amid the second wave

N Sharif, RR Opu, SN Ahmed, MK Sarkar… - Diabetes & Metabolic …, 2021 - Elsevier
Background Socio-demographics and comorbidities are involved in determining the severity
and fatality in patients with COVID-19 suggested by studies in various countries, but study in …